Friday, 26 August 2011

Systen Conti




Systen Conti may be available in the countries listed below.


Ingredient matches for Systen Conti



Estradiol

Estradiol is reported as an ingredient of Systen Conti in the following countries:


  • Poland

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Systen Conti in the following countries:


  • Slovakia

  • Switzerland

Norethisterone

Norethisterone 17ß-acetate (a derivative of Norethisterone) is reported as an ingredient of Systen Conti in the following countries:


  • Poland

  • Slovakia

  • Switzerland

International Drug Name Search

Wednesday, 24 August 2011

Tetraciclinã




Tetraciclinã may be available in the countries listed below.


Ingredient matches for Tetraciclinã



Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Tetraciclinã in the following countries:


  • Romania

International Drug Name Search

Tuesday, 23 August 2011

Kombiglyze XR


Kombiglyze XR is a brand name of metformin/saxagliptin, approved by the FDA in the following formulation(s):


KOMBIGLYZE XR (metformin hydrochloride; saxagliptin - tablet, extended release; oral)



  • Manufacturer: BRISTOL MYERS SQUIBB

    Approval date: November 5, 2010

    Strength(s): 1GM;2.5MG, 1GM;5MG [RLD], 500MG;5MG

Has a generic version of Kombiglyze XR been approved?


No. There is currently no therapeutically equivalent version of Kombiglyze XR available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Kombiglyze XR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
    Patent 6,395,767
    Issued: May 28, 2002
    Inventor(s): Jeffrey A.; Robl & Richard B.; Sulsky & David J.; Augeri & David R.; Magnin & Lawrence G.; Hamann & David A.; Betebenner
    Assignee(s): Bristol-Myers Squibb Company
    Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula where x is 0 or 1 and y is 0 or 1 (provided that x=1 when y=0 and x=0 when y=1); n is 0 or 1; X is H or CN; and wherein R1, R2, R3 and R4 are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor *or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.
    Patent expiration dates:

    • February 16, 2021
      ✓ 
      Patent use: ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH BOTH SAXAGLIPTIN AND METFORMIN IS APPROPRIATE
      ✓ 
      Drug substance
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • July 31, 2014 - NEW CHEMICAL ENTITY

See also...

  • Kombiglyze XR Consumer Information (Drugs.com)
  • Kombiglyze XR Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Kombiglyze XR Consumer Information (Cerner Multum)
  • Kombiglyze XR Advanced Consumer Information (Micromedex)
  • Saxagliptin/Metformin Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Metformin and saxagliptin Consumer Information (Cerner Multum)
  • Saxagliptin and metformin Advanced Consumer Information (Micromedex)

Monday, 22 August 2011

Tilomix




Tilomix may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Tilomix



Tylosin

Tylosin is reported as an ingredient of Tilomix in the following countries:


  • Italy

International Drug Name Search

Saturday, 20 August 2011

Nodiril




Nodiril may be available in the countries listed below.


Ingredient matches for Nodiril



Risperidone

Risperidone is reported as an ingredient of Nodiril in the following countries:


  • Indonesia

  • Malta

International Drug Name Search

Friday, 19 August 2011

Mianserin Arcana




Mianserin Arcana may be available in the countries listed below.


Ingredient matches for Mianserin Arcana



Mianserin

Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Mianserin Arcana in the following countries:


  • Austria

International Drug Name Search

Wednesday, 17 August 2011

Prindril




Prindril may be available in the countries listed below.


Ingredient matches for Prindril



Bromperidol

Bromperidol is reported as an ingredient of Prindril in the following countries:


  • Japan

International Drug Name Search

Friday, 12 August 2011

Modafen




Modafen may be available in the countries listed below.


Ingredient matches for Modafen



Ibuprofen

Ibuprofen is reported as an ingredient of Modafen in the following countries:


  • Slovakia

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Modafen in the following countries:


  • Slovakia

International Drug Name Search

Malergo




Malergo may be available in the countries listed below.


Ingredient matches for Malergo



Ergometrine

Ergometrine maleate (a derivative of Ergometrine) is reported as an ingredient of Malergo in the following countries:


  • Dominican Republic

International Drug Name Search

Monday, 8 August 2011

Piroheptine




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0016378-21-5

Chemical Formula

C22-H25-N

Molecular Weight

303

Therapeutic Category

Treatment of Parkinson's disease

Chemical Name

Pyrrolidine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-ethyl-2-methyl-

Foreign Names

  • Piroheptinum (Latin)
  • Piroheptin (German)
  • Piroheptine (French)
  • Piroheptina (Spanish)

Generic Names

  • PHT (IS)
  • FK 1190 (IS: Fujisawa)

Brand Name

  • Trimol
    Astellas, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 5 August 2011

Amicrobin




Amicrobin may be available in the countries listed below.


Ingredient matches for Amicrobin



Norfloxacin

Norfloxacin is reported as an ingredient of Amicrobin in the following countries:


  • Spain

International Drug Name Search